Is the GMP biologics market expected to continue growing at a high rate?

The global GMP biologics market is growing rapidly, expected to be valued at around US$ 52.7 billion in 2026 and projected to reach US$ 98.2 billion by 2033, with a CAGR of 9.3% during the forecast period.

• Option 1: Yes, it will continue to grow
• Option 2: The growth rate is unlikely to slow down significantly
• Option 3: No, the market will experience a decline in growth
• Option 4: There are other factors that may impact the growth rate